HLS Therapeutics Q3 2026 adjusted EBITDA rises year over year to USD 5 million
HLS Therapeutics Q3 2026 adjusted EBITDA rises year over year to USD 5 million HLS Therapeutics’
Related stories
CBOT wheat sinks to 9-month low on stronger US dollar
CBOT wheat sinks to 9-month low on stronger US dollar CHICAGO, Nov 12 (Reuters) - Chicago Board of T
L impact | COMMODITIES | Nov 12, 2026, 08:35 PM UTC
US session market picture: S&P 500 -0.25%, Nasdaq 100 -0.33%; EUR/USD -0.28%, WTI +2.8%, NVDA leads volume
US session market picture. US index futures: S and P futures is down 0.25 percent, Nasdaq futures is down 0.33 percent, Dow futures is down 0.2 percent and Russell futures is down
M impact | EQUITY | Nov 12, 2026, 08:30 PM UTC
Family Dollar to Pay $63 Million to Settle Upcharging Claims
Family Dollar agreed to pay $63 million to settle government allegations that it charged customers more at checkout than the prices displayed on shelves and tags.
M impact | REGULATION | Nov 12, 2026, 08:06 PM UTC
US session market picture: S&P 500 -0.22%, Nasdaq 100 -0.28%; EUR/USD -0.3%, WTI +2.82%, NVDA leads volume
US session market picture. US index futures: S and P futures is down 0.22 percent, Nasdaq futures is down 0.28 percent, Dow futures is down 0.14 percent and Russell futures is down
M impact | EQUITY | Nov 12, 2026, 08:00 PM UTC
CBOT Grain Futures Extend Losses as U.S. Dollar Rises
CBOT grain futures accelerated losses as the U.S. dollar reached a 19-month high, amid expectations of higher interest rates to rein in inflation. AgResourc said the stronger dolla
M impact | COMMODITIES | Nov 12, 2026, 07:38 PM UTC
US session market picture: S&P 500 -0.19%, Nasdaq 100 -0.29%; EUR/USD -0.31%, WTI +2.62%, NVDA leads volume
US session market picture. US index futures: S and P futures is down 0.19 percent, Nasdaq futures is down 0.29 percent, Dow futures is down 0.11 percent and Russell futures is down
M impact | EQUITY | Nov 12, 2026, 07:31 PM UTC